Related Experiment Video

Updated: Jun 8, 2026

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

[Clinical and genetic features of left ventricular noncompaction: a continuum in cardiomyopathies]

Massimo Baldi1, Aurelio Sgalambro, Stefano Nistri

  • 1Centro di Riferimento Regionale per le Cardiomiopatie di Firenze, Dipartimento Area Critica, Università degli Studi, Azienda Ospedaliero-Universitaria Careggi, Firenze.

Giornale Italiano Di Cardiologia (2006)
|September 24, 2010
PubMed

Insights

Isolated left ventricular non-compaction (LVNC) is a rare cardiomyopathy. Improved diagnostic criteria enhance detection, revealing potential links to other heart conditions and genetic mutations.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Diagnostics

Background:

  • Isolated left ventricular non-compaction (LVNC) is a rare genetic cardiomyopathy.
  • Characterized by prominent ventricular trabeculation and deep recesses.
  • Clinical presentation varies widely, from asymptomatic to severe heart failure and sudden death.

Purpose of the Study:

  • To discuss the diagnostic challenges and advancements in identifying LVNC.
  • To explore the association of LVNC with other cardiac disorders.
  • To investigate the potential genetic continuum between LVNC and other cardiomyopathies.

Main Methods:

  • Review of diagnostic criteria for LVNC.
  • Analysis of recent studies on LVNC prevalence and associations.
  • Exploration of genetic data linking LVNC to other cardiomyopathies.

Main Results:

  • LVNC diagnosis is often missed due to low awareness.
  • High-resolution echocardiography and cardiac MRI have improved diagnostic sensitivity.
  • LVNC is increasingly diagnosed alongside congenital heart disease and other genetic cardiomyopathies.

Conclusions:

  • Enhanced diagnostic tools are improving LVNC detection.
  • Evidence suggests a shared genetic background between LVNC and other cardiomyopathies like hypertrophic and dilated CM.
  • This genetic overlap may illuminate common pathogenic mechanisms in cardiomyopathies.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...